Skip to main content

16.03.2024 | Original Paper

Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature

verfasst von: Daniel Feingold, Dana Tzur Bitan, Marica Ferri, Eva Hoch

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience

Einloggen, um Zugang zu erhalten

Abstract

Treatment demand for Cannabis Use Disorder (CUD) has increased in the past decade in almost all European countries, and CUD is currently the most common reason for first-time drug-related treatment admission in the European Union. Even though several therapeutic approaches have been shown to benefit individuals with CUD, there is a lack of knowledge regarding factors associated with effective therapy and the underlying mechanisms of change among individuals with CUD presenting for treatment. The aim of the present paper was to review current knowledge on factors that have been shown to contribute to positive outcomes in CUD treatment. A scoping methodology was used, focusing on empirically evaluated studies that used defined, cannabis-related outcome measures. In eligible studies, factors of investigation were categorized as either ‘mediators’, i.e., treatment-related factors associated with the processes or mechanisms through which patients benefit from therapy, or 'moderators' which are patient-related characteristics that predict his/her odds to benefit from treatment or patient-related (i.e., moderators). Factors categorized as mediators were then classified ‘specific factors’ if they were related to a certain technique or treatment modality or ‘common factors’ if they were assessed beyond treatment modalities. Findings suggest that in CUD treatment, specific mediators include treatment duration, addressing motivation to change, acquiring coping skills, enhancing self-efficacy, and integrating several therapeutic components. Common mediators include therapeutic alliance, empathy, expectations and cultural adaptation. Moderators in CUD treatment include sex, ethnicity, age-related factors and comorbid disorders.
Literatur
2.
Zurück zum Zitat Amrhein PC, Miller WR, Yahne CE, Palmer M, Fulcher L (2003) Client commitment language during motivational interviewing predicts drug use outcomes. J Consult Clin Psychol 71:862PubMedCrossRef Amrhein PC, Miller WR, Yahne CE, Palmer M, Fulcher L (2003) Client commitment language during motivational interviewing predicts drug use outcomes. J Consult Clin Psychol 71:862PubMedCrossRef
3.
Zurück zum Zitat Apodaca TR, Longabaugh R (2009) Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence. Addiction 104:705–715PubMedPubMedCentralCrossRef Apodaca TR, Longabaugh R (2009) Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence. Addiction 104:705–715PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8:19–32CrossRef Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8:19–32CrossRef
5.
Zurück zum Zitat Askari MS, Keyes KM, Mauro PM (2021) Cannabis use disorder treatment use and perceived treatment need in the united states: time trends and age differences between 2002 and 2019. Drug Alcohol Depend 229:109154PubMedPubMedCentralCrossRef Askari MS, Keyes KM, Mauro PM (2021) Cannabis use disorder treatment use and perceived treatment need in the united states: time trends and age differences between 2002 and 2019. Drug Alcohol Depend 229:109154PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Bandura A, Freeman WH, Lightsey R (1999) Self-efficacy: the exercise of control. Springer Bandura A, Freeman WH, Lightsey R (1999) Self-efficacy: the exercise of control. Springer
7.
Zurück zum Zitat Banes KE, Stephens RS, Blevins CE, Walker DD, Roffman RA (2014) Changing motives for use: outcomes from a cognitive-behavioral intervention for marijuana-dependent adults. Drug Alcohol Depend 139:41–46PubMedPubMedCentralCrossRef Banes KE, Stephens RS, Blevins CE, Walker DD, Roffman RA (2014) Changing motives for use: outcomes from a cognitive-behavioral intervention for marijuana-dependent adults. Drug Alcohol Depend 139:41–46PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Benish SG, Quintana S, Wampold BE (2011) Culturally adapted psychotherapy and the legitimacy of myth: a direct-comparison meta-analysis. J Couns Psychol 58:279PubMedCrossRef Benish SG, Quintana S, Wampold BE (2011) Culturally adapted psychotherapy and the legitimacy of myth: a direct-comparison meta-analysis. J Couns Psychol 58:279PubMedCrossRef
9.
Zurück zum Zitat Bertram JR, Porath A, Seitz D, Kalant H, Krishnamoorthy A, Nickerson J, Sidhu A, Smith A, Teed R (2020) Canadian guidelines on cannabis use disorder among older adults. Can Geriatrics J 23:135CrossRef Bertram JR, Porath A, Seitz D, Kalant H, Krishnamoorthy A, Nickerson J, Sidhu A, Smith A, Teed R (2020) Canadian guidelines on cannabis use disorder among older adults. Can Geriatrics J 23:135CrossRef
10.
Zurück zum Zitat Blevins CE, Banes KE, Stephens RS, Walker DD, Roffman RA (2016) Change in motives among frequent cannabis-using adolescents: predicting treatment outcomes. Drug Alcohol Depend 167:175–181PubMedPubMedCentralCrossRef Blevins CE, Banes KE, Stephens RS, Walker DD, Roffman RA (2016) Change in motives among frequent cannabis-using adolescents: predicting treatment outcomes. Drug Alcohol Depend 167:175–181PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Blevins CE, Banes KE, Stephens RS, Walker DD, Roffman RA (2016) Motives for marijuana use among heavy-using high school students: an analysis of structure and utility of the comprehensive marijuana motives questionnaire. Addict Behav 57:42–47PubMedPubMedCentralCrossRef Blevins CE, Banes KE, Stephens RS, Walker DD, Roffman RA (2016) Motives for marijuana use among heavy-using high school students: an analysis of structure and utility of the comprehensive marijuana motives questionnaire. Addict Behav 57:42–47PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Budney AJ, Higgins ST, Radonovich KJ, Novy PL (2000) Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 68:1051PubMedCrossRef Budney AJ, Higgins ST, Radonovich KJ, Novy PL (2000) Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 68:1051PubMedCrossRef
13.
Zurück zum Zitat Budney AJ, Moore BA, Rocha HL, Higgins ST (2006) Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J Consult Clin Psychol 74:307PubMedCrossRef Budney AJ, Moore BA, Rocha HL, Higgins ST (2006) Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J Consult Clin Psychol 74:307PubMedCrossRef
14.
Zurück zum Zitat Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group (2017) Drug misuse and dependence: UK guidelines on clinical management. Department of Health, London Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group (2017) Drug misuse and dependence: UK guidelines on clinical management. Department of Health, London
15.
Zurück zum Zitat Carroll KM, Easton CJ, Nich C, Hunkele KA, Neavins TM, Sinha R, Ford HL, Vitolo SA, Doebrick CA, Rounsaville BJ (2006) The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol 74:955PubMedPubMedCentralCrossRef Carroll KM, Easton CJ, Nich C, Hunkele KA, Neavins TM, Sinha R, Ford HL, Vitolo SA, Doebrick CA, Rounsaville BJ (2006) The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol 74:955PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Carroll KM, Nich C, LaPaglia DM, Peters EN, Easton CJ, Petry NM (2012) Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less. Addiction 107:1650–1659PubMedPubMedCentralCrossRef Carroll KM, Nich C, LaPaglia DM, Peters EN, Easton CJ, Petry NM (2012) Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less. Addiction 107:1650–1659PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Connor JP, Gullo MJ, Feeney GF, Kavanagh DJ, Young RM (2014) The relationship between cannabis outcome expectancies and cannabis refusal self-efficacy in a treatment population. Addiction 109:111–119PubMedCrossRef Connor JP, Gullo MJ, Feeney GF, Kavanagh DJ, Young RM (2014) The relationship between cannabis outcome expectancies and cannabis refusal self-efficacy in a treatment population. Addiction 109:111–119PubMedCrossRef
18.
Zurück zum Zitat Connor JP, Stjepanović D, Le Foll B, Hoch E, Budney AJ, Hall WD (2021) Cannabis use and cannabis use disorder. Nat Rev Dis Primers 7:1–24CrossRef Connor JP, Stjepanović D, Le Foll B, Hoch E, Budney AJ, Hall WD (2021) Cannabis use and cannabis use disorder. Nat Rev Dis Primers 7:1–24CrossRef
19.
Zurück zum Zitat Crits-Christoph P, Gallop R, Temes CM, Woody G, Ball SA, Martino S, Carroll KM (2009) The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol 77:1125PubMedPubMedCentralCrossRef Crits-Christoph P, Gallop R, Temes CM, Woody G, Ball SA, Martino S, Carroll KM (2009) The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol 77:1125PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G (2012) The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin Psychol Rev 32:280–291PubMedCrossRef Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G (2012) The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin Psychol Rev 32:280–291PubMedCrossRef
21.
Zurück zum Zitat Cuijpers P, Reijnders M, Huibers MJ (2019) The role of common factors in psychotherapy outcomes. Annu Rev Clin Psychol 15:207–231PubMedCrossRef Cuijpers P, Reijnders M, Huibers MJ (2019) The role of common factors in psychotherapy outcomes. Annu Rev Clin Psychol 15:207–231PubMedCrossRef
22.
Zurück zum Zitat Dennis M, Godley SH, Diamond G, Tims FM, Babor T, Donaldson J, Liddle H, Titus JC, Kaminer Y, Webb C (2004) The cannabis youth treatment (cyt) study: main findings from two randomized trials. J Subst Abuse Treat 27:197–213PubMedCrossRef Dennis M, Godley SH, Diamond G, Tims FM, Babor T, Donaldson J, Liddle H, Titus JC, Kaminer Y, Webb C (2004) The cannabis youth treatment (cyt) study: main findings from two randomized trials. J Subst Abuse Treat 27:197–213PubMedCrossRef
23.
Zurück zum Zitat Diamond GS, Liddle HA, Wintersteen MB, Dennis ML, Godley SH, Tims F (2006) Early therapeutic alliance as a predictor of treatment outcome for adolescent cannabis users in outpatient treatment. Am J Addict 15:s26–s33CrossRef Diamond GS, Liddle HA, Wintersteen MB, Dennis ML, Godley SH, Tims F (2006) Early therapeutic alliance as a predictor of treatment outcome for adolescent cannabis users in outpatient treatment. Am J Addict 15:s26–s33CrossRef
24.
Zurück zum Zitat Elliott R, Bohart A, Watson J, Greenberg L (2011) Empathy. Psychotherapy 48:43–49 (10:a0022187)PubMedCrossRef Elliott R, Bohart A, Watson J, Greenberg L (2011) Empathy. Psychotherapy 48:43–49 (10:a0022187)PubMedCrossRef
25.
Zurück zum Zitat Enkema MC, Hallgren KA, Bowen S, Lee CM, Larimer ME (2021) Craving management: exploring factors that influence momentary craving-related risk of cannabis use among young adults. Addict Behav 115:106750PubMedCrossRef Enkema MC, Hallgren KA, Bowen S, Lee CM, Larimer ME (2021) Craving management: exploring factors that influence momentary craving-related risk of cannabis use among young adults. Addict Behav 115:106750PubMedCrossRef
26.
Zurück zum Zitat European Monitoring Centre for Drugs and Drug Addiction (2022) European drug report 2022: trends and developments. In: Publications Office of the European Union, Luxembourg European Monitoring Centre for Drugs and Drug Addiction (2022) European drug report 2022: trends and developments. In: Publications Office of the European Union, Luxembourg
28.
Zurück zum Zitat Feingold D, Gliksberg O (2023) Defining problematic use of medicinal cannabis: theoretical and empirical considerations. In: Preedy VR, Patel V, Martin CR (eds) Medicinal usage of cannabis and cannabinoids. Academic Press Feingold D, Gliksberg O (2023) Defining problematic use of medicinal cannabis: theoretical and empirical considerations. In: Preedy VR, Patel V, Martin CR (eds) Medicinal usage of cannabis and cannabinoids. Academic Press
29.
Zurück zum Zitat Feingold D, Livne O, Rehm J, Lev-Ran S (2020) Probability and correlates of transition from cannabis use to dsm-5 cannabis use disorder: results from a large-scale nationally representative study. Drug Alcohol Rev 39:142–151PubMedCrossRef Feingold D, Livne O, Rehm J, Lev-Ran S (2020) Probability and correlates of transition from cannabis use to dsm-5 cannabis use disorder: results from a large-scale nationally representative study. Drug Alcohol Rev 39:142–151PubMedCrossRef
30.
Zurück zum Zitat Fisher AJ, Boswell JF (2016) Enhancing the personalization of psychotherapy with dynamic assessment and modeling. Assessment 23:496–506PubMedCrossRef Fisher AJ, Boswell JF (2016) Enhancing the personalization of psychotherapy with dynamic assessment and modeling. Assessment 23:496–506PubMedCrossRef
31.
Zurück zum Zitat Flückiger C, Del Re AC, Wampold BE, Horvath AO (2018) The alliance in adult psychotherapy: a meta-analytic synthesis. Psychotherapy 55:316PubMedCrossRef Flückiger C, Del Re AC, Wampold BE, Horvath AO (2018) The alliance in adult psychotherapy: a meta-analytic synthesis. Psychotherapy 55:316PubMedCrossRef
32.
Zurück zum Zitat Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS (2005) Schizophrenia practice guidelines: international survey and comparison. Br J Psychiatry 187:248–255PubMedCrossRef Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS (2005) Schizophrenia practice guidelines: international survey and comparison. Br J Psychiatry 187:248–255PubMedCrossRef
34.
Zurück zum Zitat Gibbons CJ, Nich C, Steinberg K, Roffman RA, Corvino J, Babor TF, Carroll KM (2010) Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence. Addiction 105:1799–1808PubMedPubMedCentralCrossRef Gibbons CJ, Nich C, Steinberg K, Roffman RA, Corvino J, Babor TF, Carroll KM (2010) Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence. Addiction 105:1799–1808PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Goldin PR, Ziv M, Jazaieri H, Werner K, Kraemer H, Heimberg RG, Gross JJ (2012) Cognitive reappraisal self-efficacy mediates the effects of individual cognitive-behavioral therapy for social anxiety disorder. J Consult Clin Psychol 80:1034PubMedPubMedCentralCrossRef Goldin PR, Ziv M, Jazaieri H, Werner K, Kraemer H, Heimberg RG, Gross JJ (2012) Cognitive reappraisal self-efficacy mediates the effects of individual cognitive-behavioral therapy for social anxiety disorder. J Consult Clin Psychol 80:1034PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Goodman S, Wadsworth E, Leos-Toro C, Hammond D, team ICPS (2020) Prevalence and forms of cannabis use in legal vs. Illegal recreational cannabis markets. Int J Drug Policy 76:102658PubMedCrossRef Goodman S, Wadsworth E, Leos-Toro C, Hammond D, team ICPS (2020) Prevalence and forms of cannabis use in legal vs. Illegal recreational cannabis markets. Int J Drug Policy 76:102658PubMedCrossRef
37.
Zurück zum Zitat Gullo MJ, Matveeva M, Feeney GF, Young RM, Connor JP (2017) Social cognitive predictors of treatment outcome in cannabis dependence. Drug Alcohol Depend 170:74–81PubMedCrossRef Gullo MJ, Matveeva M, Feeney GF, Young RM, Connor JP (2017) Social cognitive predictors of treatment outcome in cannabis dependence. Drug Alcohol Depend 170:74–81PubMedCrossRef
38.
Zurück zum Zitat Gullo MJ, Papinczak ZE, Feeney GF, Young RM, Connor JP (2021) Precision mental health care for cannabis use disorder: utility of a biosocial cognitive theory to inform treatment. Front Psych 12:1010 Gullo MJ, Papinczak ZE, Feeney GF, Young RM, Connor JP (2021) Precision mental health care for cannabis use disorder: utility of a biosocial cognitive theory to inform treatment. Front Psych 12:1010
39.
Zurück zum Zitat Hai AH, Lee CS, Abbas BT, Bo A, Morgan H, Delva J (2021) Culturally adapted evidence-based treatments for adults with substance use problems: a systematic review and meta-analysis. Drug Alcohol Depend 226:108856PubMedCrossRef Hai AH, Lee CS, Abbas BT, Bo A, Morgan H, Delva J (2021) Culturally adapted evidence-based treatments for adults with substance use problems: a systematic review and meta-analysis. Drug Alcohol Depend 226:108856PubMedCrossRef
40.
Zurück zum Zitat Hall W, Lynskey M (2020) Assessing the public health impacts of legalizing recreational cannabis use: the us experience. World Psychiatry 19:179–186PubMedPubMedCentralCrossRef Hall W, Lynskey M (2020) Assessing the public health impacts of legalizing recreational cannabis use: the us experience. World Psychiatry 19:179–186PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Hendriks V, van der Schee E, Blanken P (2012) Matching adolescents with a cannabis use disorder to multidimensional family therapy or cognitive behavioral therapy: treatment effect moderators in a randomized controlled trial. Drug Alcohol Depend 125:119–126PubMedCrossRef Hendriks V, van der Schee E, Blanken P (2012) Matching adolescents with a cannabis use disorder to multidimensional family therapy or cognitive behavioral therapy: treatment effect moderators in a randomized controlled trial. Drug Alcohol Depend 125:119–126PubMedCrossRef
42.
Zurück zum Zitat Hillhouse MP, Marinelli-Casey P, Gonzales R, Ang A, Rawson RA, Authors MTPC (2007) Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction 102:84–95PubMedCrossRef Hillhouse MP, Marinelli-Casey P, Gonzales R, Ang A, Rawson RA, Authors MTPC (2007) Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction 102:84–95PubMedCrossRef
43.
Zurück zum Zitat Hodge DR, Jackson KF, Vaughn MG (2012) Culturally sensitive interventions and substance use: a meta-analytic review of outcomes among minority youths. Soc Work Res 36:11–19CrossRef Hodge DR, Jackson KF, Vaughn MG (2012) Culturally sensitive interventions and substance use: a meta-analytic review of outcomes among minority youths. Soc Work Res 36:11–19CrossRef
44.
Zurück zum Zitat Hogue A, Henderson CE, Becker SJ, Knight DK (2018) Evidence base on outpatient behavioral treatments for adolescent substance use, 2014–2017: outcomes, treatment delivery, and promising horizons. J Clin Child Adolesc Psychol 47:499–526PubMedPubMedCentralCrossRef Hogue A, Henderson CE, Becker SJ, Knight DK (2018) Evidence base on outpatient behavioral treatments for adolescent substance use, 2014–2017: outcomes, treatment delivery, and promising horizons. J Clin Child Adolesc Psychol 47:499–526PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Holmes MC, Donovan CL, Farrell LJ, March S (2014) The efficacy of a group-based, disorder-specific treatment program for childhood gad–a randomized controlled trial. Behav Res Ther 61:122–135PubMedCrossRef Holmes MC, Donovan CL, Farrell LJ, March S (2014) The efficacy of a group-based, disorder-specific treatment program for childhood gad–a randomized controlled trial. Behav Res Ther 61:122–135PubMedCrossRef
48.
Zurück zum Zitat Kazdin AE (2007) Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol 3:1–27PubMedCrossRef Kazdin AE (2007) Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol 3:1–27PubMedCrossRef
49.
Zurück zum Zitat Kilmer JR, Rhew IC, Guttmannova K, Fleming CB, Hultgren BA, Gilson MS, Cooper RL, Dilley J, Larimer ME (2022) Cannabis use among young adults in Washington state after legalization of nonmedical cannabis. Am J Public Health 112:638–645PubMedPubMedCentralCrossRef Kilmer JR, Rhew IC, Guttmannova K, Fleming CB, Hultgren BA, Gilson MS, Cooper RL, Dilley J, Larimer ME (2022) Cannabis use among young adults in Washington state after legalization of nonmedical cannabis. Am J Public Health 112:638–645PubMedPubMedCentralCrossRef
50.
51.
Zurück zum Zitat Kondo KK, Morasco BJ, Nugent SM, Ayers CK, O’Neil ME, Freeman M, Kansagara D (2020) Pharmacotherapy for the treatment of cannabis use disorder: a systematic review. Ann Intern Med 172:398–412PubMedCrossRef Kondo KK, Morasco BJ, Nugent SM, Ayers CK, O’Neil ME, Freeman M, Kansagara D (2020) Pharmacotherapy for the treatment of cannabis use disorder: a systematic review. Ann Intern Med 172:398–412PubMedCrossRef
52.
Zurück zum Zitat Lambert MJ, Barley DE (2001) Research summary on the therapeutic relationship and psychotherapy outcome. Psychotherapy 38:357CrossRef Lambert MJ, Barley DE (2001) Research summary on the therapeutic relationship and psychotherapy outcome. Psychotherapy 38:357CrossRef
53.
Zurück zum Zitat Lees R, Hines LA, D’Souza DC, Stothart G, Di Forti M, Hoch E, Freeman TP (2021) Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review. Psychol Med 51:353–364PubMedCrossRef Lees R, Hines LA, D’Souza DC, Stothart G, Di Forti M, Hoch E, Freeman TP (2021) Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review. Psychol Med 51:353–364PubMedCrossRef
54.
Zurück zum Zitat Leung J, Chan GC, Hides L, Hall WD (2020) What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addict Behav 109:106479PubMedCrossRef Leung J, Chan GC, Hides L, Hall WD (2020) What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addict Behav 109:106479PubMedCrossRef
55.
Zurück zum Zitat Lev-Ran S, Feingold D (2017) Cannabis use and its association to mental illness: a focus on mood and anxiety disorders. In: Handbook of cannabis and related pathologies. Elsevier, pp 298–307 Lev-Ran S, Feingold D (2017) Cannabis use and its association to mental illness: a focus on mood and anxiety disorders. In: Handbook of cannabis and related pathologies. Elsevier, pp 298–307
56.
Zurück zum Zitat Liddle HA (2002) Multidimensional family therapy for adolescent cannabis users, cannabis youth treatment (cyt) series, vol 5, DHHS Pub. No. 02–3660 Rockville, MD: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration Liddle HA (2002) Multidimensional family therapy for adolescent cannabis users, cannabis youth treatment (cyt) series, vol 5, DHHS Pub. No. 02–3660 Rockville, MD: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration
57.
Zurück zum Zitat Litt MD, Kadden RM, Kabela-Cormier E, Petry NM (2008) Coping skills training and contingency management treatments for marijuana dependence: exploring mechanisms of behavior change. Addiction 103:638–648PubMedPubMedCentralCrossRef Litt MD, Kadden RM, Kabela-Cormier E, Petry NM (2008) Coping skills training and contingency management treatments for marijuana dependence: exploring mechanisms of behavior change. Addiction 103:638–648PubMedPubMedCentralCrossRef
58.
Zurück zum Zitat Litt MD, Kadden RM, Petry NM (2013) Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement. Addict Behav 38:1764–1775PubMedCrossRef Litt MD, Kadden RM, Petry NM (2013) Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement. Addict Behav 38:1764–1775PubMedCrossRef
59.
Zurück zum Zitat Litt MD, Kadden RM, Stephens RS (2005) Coping and self-efficacy in marijuana treatment: results from the marijuana treatment project. J Consult Clin Psychol 73:1015PubMedCrossRef Litt MD, Kadden RM, Stephens RS (2005) Coping and self-efficacy in marijuana treatment: results from the marijuana treatment project. J Consult Clin Psychol 73:1015PubMedCrossRef
60.
Zurück zum Zitat Livne O, Shmulewitz D, Lev-Ran S, Hasin DS (2019) Dsm-5 cannabis withdrawal syndrome: demographic and clinical correlates in us adults. Drug Alcohol Depend 195:170–177PubMedCrossRef Livne O, Shmulewitz D, Lev-Ran S, Hasin DS (2019) Dsm-5 cannabis withdrawal syndrome: demographic and clinical correlates in us adults. Drug Alcohol Depend 195:170–177PubMedCrossRef
61.
Zurück zum Zitat Magill M (2015) Branding addiction therapies and reified specific factors. Addiction 110(3):415–416PubMedCrossRef Magill M (2015) Branding addiction therapies and reified specific factors. Addiction 110(3):415–416PubMedCrossRef
62.
Zurück zum Zitat Manthey J (2019) Cannabis use in Europe: current trends and public health concerns. Int J Drug Policy 68:93–96PubMedCrossRef Manthey J (2019) Cannabis use in Europe: current trends and public health concerns. Int J Drug Policy 68:93–96PubMedCrossRef
63.
Zurück zum Zitat Marcus DK, Kashy DA, Wintersteen MB, Diamond GS (2011) The therapeutic alliance in adolescent substance abuse treatment: a one-with-many analysis. J Couns Psychol 58:449PubMedCrossRef Marcus DK, Kashy DA, Wintersteen MB, Diamond GS (2011) The therapeutic alliance in adolescent substance abuse treatment: a one-with-many analysis. J Couns Psychol 58:449PubMedCrossRef
64.
Zurück zum Zitat Markland D, Ryan RM, Tobin VJ, Rollnick S (2005) Motivational interviewing and self–determination theory. J Soc Clin Psychol 24:811–831CrossRef Markland D, Ryan RM, Tobin VJ, Rollnick S (2005) Motivational interviewing and self–determination theory. J Soc Clin Psychol 24:811–831CrossRef
65.
Zurück zum Zitat McHugh RK, Votaw VR, Sugarman DE, Greenfield SF (2018) Sex and gender differences in substance use disorders. Clin Psychol Rev 66:12–23PubMedCrossRef McHugh RK, Votaw VR, Sugarman DE, Greenfield SF (2018) Sex and gender differences in substance use disorders. Clin Psychol Rev 66:12–23PubMedCrossRef
66.
Zurück zum Zitat Meier PS, Barrowclough C, Donmall MC (2005) The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction 100:304–316PubMedCrossRef Meier PS, Barrowclough C, Donmall MC (2005) The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction 100:304–316PubMedCrossRef
67.
Zurück zum Zitat Miller WR, Moyers TB (2015) The forest and the trees: relational and specific factors in addiction treatment. Addiction 110:401–413PubMedCrossRef Miller WR, Moyers TB (2015) The forest and the trees: relational and specific factors in addiction treatment. Addiction 110:401–413PubMedCrossRef
68.
Zurück zum Zitat Montgomery L, Petry NM, Carroll KM (2012) Moderating effects of race in clinical trial participation and outcomes among marijuana-dependent young adults. Drug Alcohol Depend 126:333–339PubMedPubMedCentralCrossRef Montgomery L, Petry NM, Carroll KM (2012) Moderating effects of race in clinical trial participation and outcomes among marijuana-dependent young adults. Drug Alcohol Depend 126:333–339PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Moyers T, Manuel J, Hendrikson S, Houck J, Miller M (2009) Therapeutic processes in the combined behavioral intervention. Alcohol Clin Exp Res 33:198A Moyers T, Manuel J, Hendrikson S, Houck J, Miller M (2009) Therapeutic processes in the combined behavioral intervention. Alcohol Clin Exp Res 33:198A
70.
Zurück zum Zitat Mulder R, Murray G, Rucklidge J (2017) Common versus specific factors in psychotherapy: opening the black box. Lancet Psychiatry 4:953–962PubMedCrossRef Mulder R, Murray G, Rucklidge J (2017) Common versus specific factors in psychotherapy: opening the black box. Lancet Psychiatry 4:953–962PubMedCrossRef
71.
Zurück zum Zitat Perleth M, Jakubowski E, Busse R (2001) What is ‘best practice’ in health care? State of the art and perspectives in improving the effectiveness and efficiency of the European health care systems. Health Policy 56:235–250PubMedCrossRef Perleth M, Jakubowski E, Busse R (2001) What is ‘best practice’ in health care? State of the art and perspectives in improving the effectiveness and efficiency of the European health care systems. Health Policy 56:235–250PubMedCrossRef
72.
Zurück zum Zitat Petrucci AS, LaFrance EM, Cuttler C (2020) A comprehensive examination of the links between cannabis use and motivation. Subst Use Misuse 55:1155–1164PubMedCrossRef Petrucci AS, LaFrance EM, Cuttler C (2020) A comprehensive examination of the links between cannabis use and motivation. Subst Use Misuse 55:1155–1164PubMedCrossRef
73.
Zurück zum Zitat Petry NM (2000) A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend 58:9–25PubMedCrossRef Petry NM (2000) A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend 58:9–25PubMedCrossRef
74.
Zurück zum Zitat Pham MT, Rajić A, Greig JD, Sargeant JM, Papadopoulos A, McEwen SA (2014) A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Synthesis Methods 5:371–385CrossRef Pham MT, Rajić A, Greig JD, Sargeant JM, Papadopoulos A, McEwen SA (2014) A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Synthesis Methods 5:371–385CrossRef
75.
Zurück zum Zitat Procheska JO, Redding CA, Evers K (2002) The transtheoretical model and stages of change. Health behaviour and health education 3rd edition San Francisco: Jossey-Vass:99–120 Procheska JO, Redding CA, Evers K (2002) The transtheoretical model and stages of change. Health behaviour and health education 3rd edition San Francisco: Jossey-Vass:99–120
76.
Zurück zum Zitat Raylu N, Kaur I (2012) Relationships between treatment expectations and treatment outcomes among outpatients with substance use problems. Int J Ment Heal Addict 10:607–621CrossRef Raylu N, Kaur I (2012) Relationships between treatment expectations and treatment outcomes among outpatients with substance use problems. Int J Ment Heal Addict 10:607–621CrossRef
77.
Zurück zum Zitat Schettino J, Leuschner F, Kasten L, Tossmann P, Hoch E (2015) Treatment of cannabis-related disorders in Europe. Publications Office of the European Union, Lisbon Portugal Schettino J, Leuschner F, Kasten L, Tossmann P, Hoch E (2015) Treatment of cannabis-related disorders in Europe. Publications Office of the European Union, Lisbon Portugal
78.
Zurück zum Zitat Sherman BJ, Baker NL, McRae-Clark AL (2016) Gender differences in cannabis use disorder treatment: change readiness and taking steps predict worse cannabis outcomes for women. Addict Behav 60:197–202PubMedPubMedCentralCrossRef Sherman BJ, Baker NL, McRae-Clark AL (2016) Gender differences in cannabis use disorder treatment: change readiness and taking steps predict worse cannabis outcomes for women. Addict Behav 60:197–202PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Sherman BJ, Baker NL, Schmarder KM, McRae-Clark AL, Gray KM (2021) Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women. Drug Alcohol Depend 218:108383PubMedCrossRef Sherman BJ, Baker NL, Schmarder KM, McRae-Clark AL, Gray KM (2021) Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women. Drug Alcohol Depend 218:108383PubMedCrossRef
80.
Zurück zum Zitat Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM (2017) Gender differences among treatment-seeking adults with cannabis use disorder: clinical profiles of women and men enrolled in the achieving cannabis cessation—evaluating n-acetylcysteine treatment (accent) study. Am J Addict 26:136–144PubMedPubMedCentralCrossRef Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM (2017) Gender differences among treatment-seeking adults with cannabis use disorder: clinical profiles of women and men enrolled in the achieving cannabis cessation—evaluating n-acetylcysteine treatment (accent) study. Am J Addict 26:136–144PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Spinola S, Park A, Maisto SA, Chung T (2017) Motivation precedes goal setting in prediction of cannabis treatment outcomes in adolescents. J Child Adolesc Subst Abuse 26:132–140PubMedCrossRef Spinola S, Park A, Maisto SA, Chung T (2017) Motivation precedes goal setting in prediction of cannabis treatment outcomes in adolescents. J Child Adolesc Subst Abuse 26:132–140PubMedCrossRef
82.
Zurück zum Zitat Standeven LR, Scialli A, Chisolm MS, Terplan M (2020) Trends in cannabis treatment admissions in adolescents/young adults: analysis of teds-a 1992 to 2016. J Addict Med 14:e29–e36PubMedCrossRef Standeven LR, Scialli A, Chisolm MS, Terplan M (2020) Trends in cannabis treatment admissions in adolescents/young adults: analysis of teds-a 1992 to 2016. J Addict Med 14:e29–e36PubMedCrossRef
83.
Zurück zum Zitat Stea JN, Yakovenko I, Hodgins DC (2015) Recovery from cannabis use disorders: abstinence versus moderation and treatment-assisted recovery versus natural recovery. Psychol Addict Behav 29:522PubMedCrossRef Stea JN, Yakovenko I, Hodgins DC (2015) Recovery from cannabis use disorders: abstinence versus moderation and treatment-assisted recovery versus natural recovery. Psychol Addict Behav 29:522PubMedCrossRef
84.
Zurück zum Zitat Steinberg KL, Roffman RA, Carroll KM, Kabela E, Kadden R, Miller M, Duresky D, Group MTPR (2002) Tailoring cannabis dependence treatment for a diverse population. Addiction 97:135–142PubMedCrossRef Steinberg KL, Roffman RA, Carroll KM, Kabela E, Kadden R, Miller M, Duresky D, Group MTPR (2002) Tailoring cannabis dependence treatment for a diverse population. Addiction 97:135–142PubMedCrossRef
85.
Zurück zum Zitat Strang J, Manning V, Mayet S, Ridge G, Best D, Sheridan J (2007) Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995–2005. Addiction 102:761–770PubMedCrossRef Strang J, Manning V, Mayet S, Ridge G, Best D, Sheridan J (2007) Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995–2005. Addiction 102:761–770PubMedCrossRef
86.
Zurück zum Zitat Subramaniam GA, Stitzer ML, Woody G, Fishman MJ, Kolodner K (2009) Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders. Drug Alcohol Depend 99:141–149PubMedCrossRef Subramaniam GA, Stitzer ML, Woody G, Fishman MJ, Kolodner K (2009) Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders. Drug Alcohol Depend 99:141–149PubMedCrossRef
87.
Zurück zum Zitat Perry C, Liberto J, Milliken C, Burden J, Hagedorn H, Atkinson T, McKay JR, Mooney L, Sall J, Sasson C (2022) The management of substance use disorders: Synopsis of the 2021 us department of veterans affairs and us department of defense clinical practice guideline. Ann Intern Med 175:720–731PubMedCrossRef Perry C, Liberto J, Milliken C, Burden J, Hagedorn H, Atkinson T, McKay JR, Mooney L, Sall J, Sasson C (2022) The management of substance use disorders: Synopsis of the 2021 us department of veterans affairs and us department of defense clinical practice guideline. Ann Intern Med 175:720–731PubMedCrossRef
88.
Zurück zum Zitat Uchtenhagen A, Solberg U (2007) Guidelines for the evaluation of treatment in the field of problem drug use. A manual for researchers and professionals. European Monitoring Centre for Drugs and Drug Addiction (published without author names). Lisbon Portugal Uchtenhagen A, Solberg U (2007) Guidelines for the evaluation of treatment in the field of problem drug use. A manual for researchers and professionals. European Monitoring Centre for Drugs and Drug Addiction (published without author names). Lisbon Portugal
89.
Zurück zum Zitat UNODC (2022) World drug report 2022. United Nations publication, Viena Austria UNODC (2022) World drug report 2022. United Nations publication, Viena Austria
90.
Zurück zum Zitat Ursano RJ, Bell C, Eth S, Friedman M, Norwood A, Pfefferbaum B, Pynoos J, Zatzick DF, Benedek DM, McIntyre JS (2004) Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry 161:3–31PubMed Ursano RJ, Bell C, Eth S, Friedman M, Norwood A, Pfefferbaum B, Pynoos J, Zatzick DF, Benedek DM, McIntyre JS (2004) Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry 161:3–31PubMed
91.
Zurück zum Zitat van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M (2013) Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend 133:352–359PubMedCrossRef van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M (2013) Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend 133:352–359PubMedCrossRef
92.
Zurück zum Zitat Walker D, Stephens R, Rowland J, Roffman R (2011) The influence of client behavior during motivational interviewing on marijuana treatment outcome. Addict Behav 36:669–673PubMedPubMedCentralCrossRef Walker D, Stephens R, Rowland J, Roffman R (2011) The influence of client behavior during motivational interviewing on marijuana treatment outcome. Addict Behav 36:669–673PubMedPubMedCentralCrossRef
93.
Zurück zum Zitat Walukevich-Dienst K, Neighbors C, Buckner JD (2019) Online personalized feedback intervention for cannabis-using college students reduces cannabis-related problems among women. Addict Behav 98:106040PubMedCrossRef Walukevich-Dienst K, Neighbors C, Buckner JD (2019) Online personalized feedback intervention for cannabis-using college students reduces cannabis-related problems among women. Addict Behav 98:106040PubMedCrossRef
95.
Zurück zum Zitat Wampold BE, Imel ZE (2015) The great psychotherapy debate: the evidence for what makes psychotherapy work. RoutledgeCrossRef Wampold BE, Imel ZE (2015) The great psychotherapy debate: the evidence for what makes psychotherapy work. RoutledgeCrossRef
96.
Zurück zum Zitat White AM, Jordan JD, Schroeder KM, Acheson SK, Georgi BD, Sauls G, Ellington RR, Swartzwelder HS (2004) Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Substance Abuse 25:53–59PubMedCrossRef White AM, Jordan JD, Schroeder KM, Acheson SK, Georgi BD, Sauls G, Ellington RR, Swartzwelder HS (2004) Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Substance Abuse 25:53–59PubMedCrossRef
97.
Zurück zum Zitat World Health Organization (2020) International standards for the treatment of drug use disorders: revised edition incorporating results of field-testing. Geneva: World Health Organization and United Nations Office on Drugs and Crime; 2020. License: CC BYNC-SA 3.0 IGO World Health Organization (2020) International standards for the treatment of drug use disorders: revised edition incorporating results of field-testing. Geneva: World Health Organization and United Nations Office on Drugs and Crime; 2020. License: CC BYNC-SA 3.0 IGO
98.
Zurück zum Zitat Zilcha-Mano S (2019) Major developments in methods addressing for whom psychotherapy may work and why. Psychother Res 29:693–708PubMedCrossRef Zilcha-Mano S (2019) Major developments in methods addressing for whom psychotherapy may work and why. Psychother Res 29:693–708PubMedCrossRef
99.
Zurück zum Zitat Zvolensky MJ, Vujanovic AA, Bernstein A, Bonn-Miller MO, Marshall EC, Leyro TM (2007) Marijuana use motives: a confirmatory test and evaluation among young adult marijuana users. Addict Behav 32:3122–3130PubMedPubMedCentralCrossRef Zvolensky MJ, Vujanovic AA, Bernstein A, Bonn-Miller MO, Marshall EC, Leyro TM (2007) Marijuana use motives: a confirmatory test and evaluation among young adult marijuana users. Addict Behav 32:3122–3130PubMedPubMedCentralCrossRef
Metadaten
Titel
Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature
verfasst von
Daniel Feingold
Dana Tzur Bitan
Marica Ferri
Eva Hoch
Publikationsdatum
16.03.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-024-01781-4

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.